Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Decibel Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −10 vs. Q2 2021
- Shares held
- 18.9M
- −673.6K (−3.4%) vs. Q2 2021
- Total value
- $145.9M
- −$22.2M (−13.2%) vs. Q2 2021
- New holders
- 4
- 8 more added
- Sold out
- 14
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,945,192 | $38.1M | 0.42% | 00.0% | Unchanged |
| TRV GP III, LLC | 3,139,685 | $24.2M | 4.60% | 00.0% | Unchanged |
| BlackRock Inc. | 1,821,550 | $14.0M | 0.00% | −2,760−0.2% | Reduced |
| Citadel Advisors LLC | 1,777,659 | $13.7M | 0.02% | +3,828+0.2% | Added |
| Alphabet Inc. | 1,636,258 | $12.6M | 0.30% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,170,048 | $9.02M | 0.23% | −1,373−0.1% | Reduced |
| Samsara BioCapital, LLC | 826,422 | $6.37M | 1.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 625,215 | $4.82M | 0.00% | +253,441+68.2% | Added |
| Bessemer Group Inc | 494,071 | $3.81M | 0.01% | 00.0% | Unchanged |
| Harvard Management Co Inc | 328,798 | $2.54M | 0.15% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 297,711 | $2.29M | 0.34% | 00.0% | Unchanged |
| Woodline Partners LP | 280,473 | $2.16M | 0.04% | −380.0% | Reduced |
| Suvretta Capital Management, LLC | 263,600 | $2.03M | 0.03% | 00.0% | Unchanged |
| Credit Suisse AG | 251,950 | $1.94M | 0.00% | −1,901−0.7% | Reduced |
| FMR LLC | 213,800 | $1.65M | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 165,369 | $1.27M | 0.00% | −51,353−23.7% | Reduced |
| Bronte Capital Management Pty Ltd. | 159,462 | $1.23M | 0.18% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 114,928 | $886.0K | 0.02% | +42,928+59.6% | Added |
| Geode Capital Management, LLC | 69,556 | $536.0K | 0.00% | −2,292−3.2% | Reduced |
| Neuberger Berman Group LLC | 43,535 | $336.0K | 0.00% | +185+0.4% | Added |
| Atlas Capital Advisors LLC | 41,025 | $316.3K | 0.05% | +23,227+130.5% | Added |
| Millennium Management LLC | 38,536 | $297.0K | 0.00% | −31,381−44.9% | Reduced |
| AlphaCentric Advisors LLC | 37,500 | $289.0K | 0.07% | −7,500−16.7% | Reduced |
| Morgan Stanley | 28,154 | $217.0K | 0.00% | −47,233−62.7% | Reduced |
| Bank of New York Mellon Corp | 27,310 | $211.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,426 | $173.0K | 0.00% | +22,426 | New |
| Ergoteles LLC | 19,968 | $154.0K | 0.01% | +19,968 | New |
| Bank of America Corp | 19,273 | $148.0K | 0.00% | +18,081+1,516.9% | Added |
| State Street Corp | 15,700 | $121.0K | 0.00% | +15,700 | New |
| Northern Trust Corp | 15,239 | $117.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 15,053 | $116.0K | 0.00% | −5,252−25.9% | Reduced |
| Federated Hermes, Inc. | 15,000 | $116.0K | 0.00% | +5,000+50.0% | Added |
| Royal Bank of Canada | 2,075 | $16.0K | 0.00% | +269+14.9% | Added |
| Optiver Holding B.V. | 867 | $7.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 44 | $0 | 0.00% | −2−4.3% | Reduced |
| Evoke Wealth, LLC | 100 | $0 | 0.00% | +100 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −682,597−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,001−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −27,047−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −13,594−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −12,821−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,742−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −514−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −52−100.0% | Sold out |